Væksthormon

AMATO G, CARELLA C, FAZIO S, LA MONTAGNA G, CITTADINI A, SEBATINI D, MARCIANO-MONE C, SACCÁ L, BELLASTELLA A. Body composition, Bone Metabolism, and Heart structure and function in growth hormone (GH)-deficient adults before and after GH Replacement therapy at low doses. J Clin Endocrinol Metab 1993 77:1671-1676.

 

AZAGURY M, DOMBRET H, CASTAIGNE S, DEGOS L. Growth hormone and acute promyelocytic leukaemia. Med Pediatr Oncol 1995 24:69-70.

 

BAKER DL, KEES UR, PRICE PJ, WILLOGHBY ML. Late leukemic relapse 10 years from diagnosis in a child on recombinant human growth hormone. Pediatr Hematol Oncol 1993 10:55-62.

 

BARTKE A, CECIM M, TANG K, STEGER RW, CHANDRASHEKAR V, TURYN D. Minireview: neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice (43771). Psebm 1994 206:345-359.

 

Barton js, gardiner hm, cullen s, hindmarch pc, brook cgd, preece ma. The growth and cardiovascular effects of high dose growth hormone therapy in idiopathic short stature. Clin Endocrinol (Oxf) 1995 42:619-626.

 

BENGTSSON B-Å, EDÉN S, ERNEST I, ODÉN A, SJÖGREN B. Epidemiology and long-term survival in acromegaly. Acta Med Scand 1988 223:327-335.

 

BENGTSSON B-Å, EDÉN S, LÖNN L, KVIST H, STOKLAND A, LINDSTEDT G, BOSAEUS I, TÖLLI J, SJÖSTRÖM L, ISAKSSON OGP. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993 76:309-317.

 

BENGTSSON B-Å. Råd om terapi för vuxna ned hypofysinsufficiens. LÄKARTIDNINGEN 1995 92:993-995.

 

BOTERO D, DANON M, BROWN RS. Symptomatic non-insulin-dependent diabetes mellitus during therapy with recombinant human growth hormone. J Pediatr 1993 123:590-592.

 

BUCHANAN CR, PREECE MA, MILNER RDG. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ 1991 302:824-828.

 

COHN L, FELLER AG, DRAPER MW, RUDMAN IW, RUDMAN D. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Clin Endocrinol 1993 39:417-425.

 

CORPAS E, HARMAN SM, BLACKMAN MR. Human growth hormone and human aging. Endocr Rev 1993 14:20-39.

 

CRIST DM, PEAKE GT, EGAN PA, WATERS DL. Body composition response to exogenous GH during training in highly conditioned adults. J Appl Physiol 1988 65:579-584.

 

CRIST DM, PEAKE GT, LOFTFIELD RB, KRANER JC, EGAN PA. Supplemental growth hormone alters body composition, muscle protein metabolisme and serum lipids in fit adults: characterization of dose-dependent and response-recovery effects. Mechanisms of Aging and Development 1991 58:191-205.

 

CUNEO RC, SALOMON F, WILES CM, HESP R, SÖNKSEN PH. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. J Appl Physiol 1991a 70:688-694.

 

CUNEO RC, SALOMON F, WILES CM, HESP R, SÖNKSEN PH. Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol 1991b 70:695-700.

 

CUNEO RC, SALOMON F, WILMSHURST P, BYRNE C, WILES CM, HESP R, SÖNKSEN PH. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the rennin-aldosterone system. Clin Sci 1991c 81:587-592.

 

CZERNICHOW P. Growth hormone administration and carbohydrate metabolism. Horm Res 1993 39:102-103.

 

DAVIDSON MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 1987 8:115-131.

 

DE BOER H, BLOK G-J, VOERMAN B, DE VRIES P, POPP-SNIJDERS C, VAN DER VEEN E. The optimal growth hormone replacement dose in adults derived from bioimpendance analysis. J Clin Endocrinol Metab 1995 80:2069-2076.

 

DE BOER H, BLOK G-J, VAN DER VEEN EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995 16:63-86.

 

DEGERBLAD M, ALMKVIST O, GRUNDITZ R, HALL K, KAIJSER L, KNUTSSON E, RINGERTZ H, THOREN M. Physical and psysiological capabillities during substition therapy with recombined growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Copenh) 1990 123:185-193.

 

DEYSSIG R, FRISCH H, BLUM WF, WALDHOR T. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol 1993 128:313-318.

 

DIMARTINO-NARDI J, WESOLY S, SCHWARTZ L, SAENGER P. Lack of clinical evidence of sodium retention in children with idiopathic short stature treated with recombinant growth hormone. Metabolism 1993 42:730-734.

 

DI PASQUALE MG. Unfavorable clinical events linked directly tocontaminants and to the biological actions of growth hormone. Drugs in sports 1994 2:24-27.

 

DUCHAINE D. Underground steroid handbook II, HLR Technical Books, Venice, California, USA. 1989.

 

EZZAT S, MELMED S. Clinical review 18: are patients with acromegaly at increased risk for neoplasia? J Clin Endocrinol Metab 1991 72:245-249.

 

FASS 1996. Läkemedelsinformation AB.

 

FHÖLENHAG KI, SANDSTRÖM IM, MALMLÖF K, SKOTTNER AI, NYBERG FJ. Human growth hormone does not cross the placenta of the pregnant rat. Growth Regul 1994 4:181-187.

 

FRADKIN JE, MILLS JL, SCHONBERGER LB, WYSOWSKI DK, THOMSON R, DURAKO SJ, ROBINSON LL. Risk of leukaemia after treatment with pituitary growth hormone. JAMA 1993 270:2829-2832.

 

FRASIER SD, FOLEY TP Jr. Clinical review 58: Creutzfeldt-Jakob disease in recipients of pituitary hormones. J Clin Endocrinol Metab 1994 78:1277-1279.

 

FRYBURG DA, GELFAND RA, BARRETT EJ. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991 260:E499-E504.

 

GARG AK. Hyperglycemia during replacement growth hormone therapy. J Pediatr 1994 125:329

 

GERRA G, CACCAVARI R, FONTANESI B, MARCATO A, FERTONANI AFFINI G, MAESTRI D, AVANZINI P, LECCHINI R, DELSIGNORE R, MUTTI A. Flumazenil effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol 1994 9:211-215.

 

GERRRA G, CACCAVARI R, FONTANESI B, FERTONANI AFFINI G, MAESTRI D, AVANZINI P, ZAIMOVIZ A, FRANCHINI D, DELSIGNORE R. Naloxone and metergoline effects on growth hormone response to gamma-hydroxybutyric acid. Int Clin Psychopharmacol 1995 10:245-250.

 

GREENSPAN FS. Basic and clinical endocrinology. Appleton & Lange, East Norwalk, Connecticut, USA. 1991.

 

HASEGAWA T, HASEGAWA Y, KOTO S, ASO T, TSUCHIYA Y, HAYASHI A, ISHIDA H, MORIKAWA Y. Malignant thymoma in a patient with growth hormone deficiency during growth hormone therapy. Eur J Pediatr 1993 152:802-804.

 

HAYMOND MW, HORBER FF. The effects of human growth hormone and prednisone on whole body estimates of protein metabolism. Horm Res 1992 38(Suppl 2):44-46.

 

HINTZ RL, ROSENFELD RG, WILSON DM, BENNETT A, FINNO J,  McCLELLAN B, SWIFT R. Biosynthetic methionyl human growth hormone is biologically active in adult man. Lancet 1982 1:1276-1279.

 

INADA S, SHIDA K, MOURI Y, SAKAI R, KOGA H, MIYAZAKI S, OKAMURA J, ANAMI K, EGUCHI M. Occurrence of acute megakaryoblastic leukaemia in a patient with idiopathic growth hormone deficiency. Acta Paediatr Jpn 1995 37:222-226.

 

JOHANSSON J-O, LARSON G, ANDERSSON M, ELMGREN A, HYNSJÖ L, LINDAHL A, LUNDBERG P-A, ISAKSSON OGP, LINDSTEDT S, BENGTSSON B-Å. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrionology 1995 61:57-66.

 

JØRGENSEN JOL, THUESEN L, MÜLLER J, OVESEN P, SKAKKEBAEK NE, CHRISTIANSEN JS. Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 1994 130:224-228.

 

JØRGENSEN KD, SVENDSEN O, AGERGAARD N, SKYDSGAARD K. Effect of human growth hormone on the reproduction of female rats. Pharmacol Toxicol 1991 68:14-20.

 

KATZ E, RICCIARELLI E, ADASHI EY. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril 1993 59:8-34.

 

KIESS W, BUTENANDT O. Development of Dupuytren’s contracture during growth hormone therapy. Lancet 1993 342:181-182.

 

KNOX JB, DEMLING RH, WILMORE DW, SARRAF P, SANTOS AA. Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit. Arch Surg 1995 130:442-445.

 

LUOMA TC. IGF-I, possibly the most potent bodybuilding drug ever! And only a phone call away? Muscle media 2000. Golden, Colorado, USA. 1995 Issue no. 44:118-121.

 

MACINTYRE JG. Growth hormone and athletes. Sports Med 1987 4:129-142.

 

MALOZOWSKI S, HUNG W, SCOTT DC, STADEL BV. Acute pancreatitis associated with growth hormone therapy for short stature. N Engl J Med 1995a 332:401-402.

 

MALOZOWSKI S, STADEL BV. Prepubertal gynecomastia during growth hormone therapy. J Pediatr 1995 126:659-661.

 

MALOZOWSKI S, TANNER LA, WYSOWSKI DK, FLEMING GA. Growth hormone, insulin-like growth factor I, and benign intracranial hypertension. N Engl J Med 1993 329:665-666.

 

MALOZOWSKI S, TANNER LA, WYSOWSKI DK, FLEMING GA, STADEL BV. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr 1995b 126:996-999.

 

MOXLEY III RT. Potential for growth factor treatment of muscle disease. Curr Opin Neurol 1994 7:427-434.

 

MURPHY WJ, RUI H, LONGO DL. Minireview: effects of growth hormone and prolactin immune development and function. Life Sci 1995 57:1-14.

 

OLIVECRONA H, ERICSSON S, BERGLUND L, ANGELIN B. Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment. BMJ 1993 306:1726-1727.

 

PARKER ML, HAMMOND JM, DAUGHADAY WH. The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J Clin Endocrinol Metab 1967 27:1129-1136.

 

POWRIE J, WEISSBERGER A, SÖNKSEN P. Growth hormone replacement therapy for growth hormone-deficient adults. Drugs 1995 49:656-663.

 

PRICE DA, CLAYTON PE, LLOYD IC. Benign intracranial hypertension induced by growth hormone treatment. Lancet 1995 345:458-459.

 

RABEN MS, HOLLENBERG CH. Effect of growth hormone on plasma fatty acids. J Clin Invest 1959 38:484-488.

RANKE MB. Effects of growth hormone on the metabolism of lipids and water and their potential in causing adverse events during growth hormone treatment. Horm Res 1993 39:104-106.

 

RAPAPORT R, OBERFIELD SE, ROBINSONL, SALISBURY S, DAVID R, RAO J, REDMOND GP. Relationship of growth hormone deficiency and leukaemia. J Pediatr 1995 126:759-761.

 

RIEDEL M, BRABANT G, RIEGER K, VON ZUR MÜHLEN A. Growth hormone therapy in adults: rationales, results, and perspectives. Exp Clin Endocrinol 1994 102:273-283.

 

RITZÉN EM. Does growth hormone increase the risk of malignancies? Horm Res 1993 39:99-101.

 

RITZÉN EM, CZERNICHOW P, PREECE M, RANKE M, WIT JM. Safety of human growth hormone therapy. Horm Res 1993 39:92-93.

 

ROSÉN T. Growth hormone deficiency in adults. Thesis, university of Gothenburg. 1993 pp1-75.

 

ROSÉN T EDÉN S, LARSON G, WILHELMSEN L, BENGTSSON BÅ. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993a 129:195-200.

 

ROSÉN T, HANSSON T, GRANHED H, SZÜCS J, BENGTSSON BÅ. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol 1993c 129:201-208.

 

ROSÉN T, JOHANNSSON G, JOHANSSON´J-O, BENGTSSON B-Å. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. Horm Res 1995 43:93-99.

 

ROSENFELD RG, BENGTSSON B-Å. Effects of growth hormone and insulin-like growth factors on the central nervous system. Acta Paediatr Suppl 1994 406:89-91.

 

RUDMAN D, FELLER AG, NAGRAJ HS, GERGANS GA, LALITHA PY, GOLDBERG AF, SCHLENKER RA, COHN L, RUDMAN IW, MATTSON DE. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990 323:1-6.

 

SACCA L, CITTADINI A, FAZIO S. Growth hormone and the heart. Endocr Rev 1994 15:555-573.

 

SALOMON F, CUNEO RC, HESP R, SÖNKSEN PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989 321:1797-1803.

 

SASSOLAS G. Potential theraputic applications of growth hormone in adults. Horm Res 1994 42:72-78.

 

SCHMID H, HAUFFA BP. Acceleration of epiphyseolysis capitis femoris lenta as a complication of growth hormone therapy in hypophyseal insufficiency. Klin Pädiatr 1993 205:59-63.

 

SMITH DA, PERRY PJ. The efficacy of ergogenic agents in athletic competition part II: other performance-enhancing agents. Ann Pharmacother 1992 26:653-659.

STAHNKE N. Leukemia in growth-hormone-treated patients: an update, 1992. Horm Res 1992 38 Suppl 1:56-62.

 

STROBL JS, THOMAS MJ. Human growth hormone. Pharmacol Rev1994 46:1-34.

 

TAAFFE DR,JIN IH, VU TH, HOFFMAN AR, MARCUS R. Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-Insulin-Like growth factor expression in resistance-trained elderly men. J Clin Endocrinol Metab 1996 81:421-425.

 

TEDESCHI B, SPADONI GL, SANNA ML, VERNOLE P, CAPOROSSI D, CIANFARANI S, NICOLETTI B, BOSCHERINI B, Increased chromosome fragility in lymphocytes of short normal children treated with recombinant human growth hormone. Hum Genet 1993 91:459-463.

 

THOBURN R. Insulin- like growth factor I. Drugs in sports 1995 3:12-15.

 

THUESEN L, CHRISTIANSEN JS, SØRENSEN KE, JØRGENSEN JOL, ØRSKOV H, HENNINGSEN P. Increased myocardial contractillity following growth hormone administration in normal man. Dan Med Bull 1988 35:193-196.

 

THUESEN L, JØRGENSEN JOL, MÜLLER JR, KRISTENSEN BØ, SKAKKEBAEK NE, VAHL N, CHRISTIANSEN JS. Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol 1994 41:615-620.

 

WERNERMAN J. Effect of growth hormone on muscle and protein in critically ill patients. Acta Endocrinol 1993 128 (suppl 2): 19-22.

 

WILMORE DW, MOYLAN JA Jr, BRISTOW BF, MASON AD Jr, PRUITT BA Jr. Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynaecol Obstet 1974 138:875-884.

 

YARASHESKI KE, CAMPBELL JA, SMITH K, RENNIE MJ, HOLLOSZY JO, BIER DM. Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol 1992 262:E261-E267.

 

YARASHESKI KE, ZACHWIEJA JJ, ANGELOPOULOS JT, BIER DM. Short-term growth hormone treatment does not increase muscle protein synthesis in experienced weight lifters. J Appl Physiol 1993 74:3073-3076.

 

YARASHESKI KE, ZACHWIEJA JJ. Growth hormone therapy for the elderly: the fountain of youth proves toxic. JAMA 1993 270:1694.

 

YORDAM N, KANDEMIR N, TOPALOGLU H, GÖGÜS S, KÜCÜKALI T. Myositis associated with growth hormone therapy. J Pediatr 1994 125:671.

 

ZADIK ZVI, CHALEW SA, McCARTERRJ Jr, MEISTAS M, KOWARSKI AA. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab 1985 60:513-516.

 

ZIEGLER TR, LEADER I. Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients. Sem Resp Infect 1994 9:240-247.